E-MAIL FOR SPONSORSHIP

Concord Biotech to Procure Wind-Solar Power from CleanMax’s Project

The pharmaceutical company acquired a 26% stake in CleanMax Everglades

January 17, 2025

/ Staff
/ Finance and M&A, Solar
thumbnail

Follow Mercom India on WhatsApp for exclusive updates on clean energy news and insights


Ahmedabad-based pharmaceutical company Concord Biotech has entered into a strategic agreement to acquire a 26% equity stake in CleanMax Everglades, a CleanMax Enviro Energy Solutions special purpose vehicle that is setting up a renewable energy project with a total capacity of 9.9 MW.

ℹ️ This article is free for registered users. Sign in to continue reading.

Sign In to Continue Reading

Create a free account to access the full article and exclusive features from Mercom India's renewable energy coverage.

✓Access to free articles and news
✓Save articles for later reading
✓Personalized content recommendations
✓Newsletter subscriptions
Sign Up FreeLog In
thumbnail

Staff

More articles from Staff.
Clean Max EvergladesConcord BiotechGujaratRenewable EnergySolar-wind Hybrid
PREVALL POSTSNEXT

RELATED POSTS

Get the most relevant India solar and clean energy news.

RECENT POSTS